📺 Panel Discussion from #ACC26: Dive into the 🆕 Dyslipidemia Guideline and VESALIUS-CV Late-Breaking Clinical Trial with Drs. Fred M. Kusumoto, R. Scott Wright and Eugene Yang.
Watch now on #ACCAnywhere TV! ➡️ https://bit.ly/4c2CRXU
📣 #ACC26 Attendees: Catch up on sessions you missed with access to 200+ sessions from ACC.26 on demand. Your ACC.26 registration includes a three-month FREE trial to #ACCAnywhere.
Activate your ACC Anywhere subscription and continue your learning ➡️ https://bit.ly/3NSOkkM
We're kicking off #ACCAnywhere TV coverage of #ACC26 with Drs. Fred Kusumoto & Elizabeth Dineen in New Orleans as they preview today's pre-conferences & 3️⃣ positively paramount "Ps" of this year's annual scientific sessions! (Hint: 🏓 🐾🎓)
🔗 More 🎥 coverage to come: https://bit.ly/4bRyYEW
#CardioSky
Drs. Fred M. Kusumoto and Elizabeth H Dineen share what they’re most excited about at #ACC26, from pre-conference sessions to late-breaking clinical trials.
📹 Watch the video 👇 and learn more about everything ACC.26 has to offer ➡️ https://bit.ly/4pKcISv
#ACCAnywhere #CardioSky #MedSky
#FusterCVS 2025: Dr. W. Timothy Garvey discussed obesity as a major epidemiological challenge, comparing the short- & long-term outcomes of bariatric surgery & emerging pharmacotherapies.
📹 Watch now on #ACCAnywhere ➡️ https://bit.ly/3MXZK5Z
#CardioSky #MedSky
Learn more about #ACHD in specific patient populations with a Q&A panel from 2025 #ACCCardioOB course. Experts answer all your questions on ACHD in pregnancy.
🎥 Watch now on #ACCAnywhere ➡️ https://bit.ly/4s7P7O5
#CardioObstetrics #CardioSky #MedSky
Is Targeting Obesity a Future of CV Medicine? A session from the 2024 #FusterCVS answers the question by exploring the promising effects of GLP1-RA semaglutide in reducing MACE & ↗️ symptoms in obesity-related #HFpEF, & more.
🎥 Watch now on #ACCAnywhere! https://bit.ly/3L2yTVv
Hear insights from #ACCPresident Christopher M. Kramer, MD, FACC, on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care.
Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social
#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study.
Get the full details here: https://bit.ly/4oBNohQ
#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
That's a wrap!📺 #ESCCongress concludes today and Dr. Fred Kusumoto chatted w/ Dr. Manuel Anguita Sánchez about #heartfailure trials from throughout the Congress, including PARACHUTE-HF. Watch a clip below ⬇️
#ACCAnywhere TV Daily Wrap Up 4 full version🔗
#ESCCongress concludes today! Dr. Fred Kusumoto chatted w/ Dr. Manuel Anguita Sánchez about #heartfailure trials, including PARACHUTE-HF from Hot Line 9. Watch a clip below ⬇️
📺 #ACCAnywhere TV Day 4 Wrap Up full version: https://bit.ly/4lXncMp
📺 #ACCAnywhere TV From #ESCCongress | Day 3 Wrap Up focuses on interventional cardiology trials presented today, specifically NEO-MINDSET & TARGET-FIRST. #ACCAsia Co-Chair Dr. Kwan Le provides the top level highlights alongside ACC Clinical Content Editor-in-Chief Dr. Fred Kusumoto ⬇️
❤️ Heart Failure in focus at #ESCCongress. #JACCHF Editor-in-Chief Dr. Biykem Bozkurt highlights key science from Hot Line 2.
📺 Watch her Quick Takes now with #ACCAnywhere TV from ESC Congress in Madrid ⬇️
📺 It's time for another #ACCAnywhere TV From #ESCCongress Daily Wrap Up! ACC Clinical Content Editor-in-Chief Dr. Fred Kusumoto discusses CVD prevention 🔥 trials of the day with ACC's Prevention of CVD Member Section Chair Dr. @Eugenia Gianos. #cvPrev #ACCPrev https://bit.ly/4mE7bfi
📺 ACC Anywhere TV From ESC Congress 2025 Quick Takes on Hypertension:
🗨️ "Lets get hypertension under control so that we can truly start to reduce that global burden of heart disease." - @cathiebiga.bsky.social
More: https://bit.ly/45NR6MQ
#ACCAnywhere #ESCCongress #Hypertension
🎥 #ACCAnywhere TV From #ESCCongress 2025 Quick Takes: Dr. Milind Y. Desai shares key takeaways from the ODYSSEY-HCM trial, a study of mavacamten in non-obstructive hypertrophic cardiomyopathy, with #JACC Associate Editor Dr. Michelle M. Kittleson.
More: https://bit.ly/3HT8FDt
#cvHCM #JACCJournals
📺 #ACCAnywhere TV Quick Takes: Tackling the burden of CV disease requires 🌍 collaboration. Hear from #ACCPresident Dr. Christopher Kramer at the start of #ESCCongress 2025 about the College's commitment to transforming CV care & improving 🫀 health for all.
#ACCIntl #JACC
Don't miss a moment of our coverage of all the 🔥 hot science from #ESCCongress 2025 in Madrid!
📌 Bookmark the feed: https://bit.ly/3HnZ87f
Plus, catch our daily wrap ups and quick takes via 📺 ACC Anywhere TV From ESC Congress 2025 here on social, YouTube & #ACCAnywhere!
#CardioSky #MedSky
As we look back on #ACC25, hear from Saraschandra Vallabhajosyula, MBBS, FACC, as he discusses results from the Altshock-2 trial, simultaneously published in #JACC.
More on #ACCAnywhere TV From ACC.25 ➡️ bit.ly/3xlSQQ5
@jaccjournals.bsky.social
🆕on ACC Anywhere TV From ACC.25: William Schuyler Jones, MD, FACC, discusses results of the SOUL trial. 💊
📽️More on #ACCAnywhere here: accanywhere.acc.org
#ACC25 #CardioSky #MedSky #Semaglutide
